Skip to content

Uroflowmetry and Nocturnal Enuresis

Is Uroflowmetry Useful in Assessing Response to Pharmacological Treatment in Enuresis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07028645
Enrollment
100
Registered
2025-06-19
Start date
2022-08-20
Completion date
2025-12-30
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Enuresis, Nocturnal

Keywords

Uroflowmetry, Enuresis

Brief summary

This study will evaluate the uroflowmetry parameters of patients which were treated for enuresis.

Detailed description

A total of approximately 100 patients with enuresis will be evaluated retrospectively. Uroflowmetry parameters of these patients will be evaluated. For this purpose, patients will be divided to mainly three groups according to the treatment choices.

Interventions

Desmopressin 120 mcg will be used frist-line drug in the treatment of enuresis.

Desmopressin 240 mcg will be used for the patients who have not responsive to desmopressin 120 mcg.

Propiverine (a dose of 0.8 mg/ kg) will be used for the patients who have -response to treatment with desmopressin 240 mcg

Sponsors

Furkan Adem Canbaz
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
5 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* Presence of enuresis nocturna * Patients who have uroflowmetry test

Exclusion criteria

* Presence of lower urinary tract symptoms * Presence of anatomical or neurological problems * Patients with missing data

Design outcomes

Primary

MeasureTime frameDescription
Number of days without bedwetting1 monthAchievement of bedwetting in one or less night of a month

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026